位于斯德哥尔摩的数字医疗保健提供者克里, calledLivi在英国和法国，raised €262 millionin a Series D round in May, highlighting how investor interest in healthtech is not abating, even as coronavirus lockdowns lift and people can go back to their doctors.
“The underlying megatrend was obviously there before the pandemic, and a lot of the big policy changes in Europe had actually been implemented before the pandemic,” Kry CEO and co-founderJohannes Schildt告诉Tech.eu在一个强度rview, adding that the virus outbreak has simply ensured that what they offer will be part of any healthcare system moving forward.
克里puts patients in contact with doctors and other health professions for remote video consultations via their telemedicine platform. In 2020, it expanded outside of Europe with the launch of its Kry Connect video-consultation appin the US.
Founded in 2015, Kry is now present in five EU markets, where it also employs and trains it own local clinicians and partners with third-party clinics. In March this year, it merged with Swedish healthcare company Helsa, and took over its physical health centres.
In terms of international expansion strategy, Schildt says regulatory frameworks are always the biggest questions when it comes to launching in a new market — in some places, it may not even be legal to offer their services at all.他说：“在某些市场中，如果您与患者不在同一房间，您将无法诊断。”
The second big consideration is how to create a functional business model so they get paid for delivering their tools and services. Unlike in the US, where private healthcare companies and employers pay for health services, in Europe it is usually public health systems and larger private insurance companies.
“On the payer side there is obviously a difference between addressing the National Health services in the UK, versus Sweden, versus the public payers of France for example, or a private payer or going directly to the consumer.”
“You look into the maturity of the market and if there is any existing infrastructure you could use— e-prescriptions for example,” Schildt says. “In Sweden, there’s a fairly well-built system that we can use nationwide to do e-prescriptions and in France there was nothing—when we initially launched we built that ourselves in two weeks and scaled it nationwide.”
"In Sweden, theres a huge accessibility problem," he says. "You see that in a lot of European countries there are a lot of inequalities when it comes to access, depending on where you live and who you are."
Even though European countries have no shortage of highly skilled healthcare professionals, Schildt says that "an inefficiency problem within in the system leads to inequalities within access."
You can listen to our full podcast interview below: